الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 107 |  |  |
| | | from | 107 | | |
Abstract
Acute coronary syndrome (ACS) refers to the constellation of clinical diseases occurring as a result of acute myocardial ischemia. ACS includes a spectrum of clinical presentations ranging from unstable angina (UA) to acute myocardial infarction (AMI), including two AMI subtypes, non–ST segment elevation myocardial infarction (NSTEMI) and ST segment elevation myocardial infarction (STEMI).
Approximately 80% of patients with known CAD had at least one of the four conventional risk factors diabetes mellitus, cigarette smoking, hypertension and hyperlipidemia.
Diabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of different organs, especially the eyes, kidneys, nerves, heart, and blood vessels.
Coronary heart disease (CHD) is the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes. Common conditions coexisting with type 2 diabetes (e.g., hypertension, obesity and dyslipidemia) are clear risk factors for ASCVD, but diabetes itself confers independent risk. Numerous studies have shown the efficacy of controlling individual cardiovascular risk factors in preventing or slowing ASCVD in people with diabetes. Therefore, cardiovascular risk factors should be systematically assessed at least annually in all patients with diabetes.
Consequently, the diabetic patient needs special management and monitoring, with a view to the prevention, control, and treatment of the various manifestations of coronary artery disease, so all patients with ACS require evidence‑based treatment such as lifestyle modification and drugs to prevent death and secondary complications.
The aim of the present work was to assess clinical presentation, risk factors and short-term out come in ACS patients with or without diabetes and to show how far diabetes mellitus impact the prognosis of patients with ACS.